NA
CVS icon

NewEdge Advisors’s CVS Health CVS Stock Holding History

NewEdge Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.4M Buy
130,922
+23,233
+22% +$1.79M 0.03% 476
2025
Q4 		$8.55M Buy
107,689
+24,608
+30% +$1.94M 0.03% 485
2025
Q3 		$6.26M Sell
83,081
-2,188
-3% -$150K 0.03% 541
2025
Q2 		$5.88M Sell
85,269
-13,907
-14% -$912K 0.03% 517
2025
Q1 		$6.72M Buy
99,176
+41,871
+73% +$2.51M 0.04% 422
2024
Q4 		$2.57M Sell
57,305
-4,749
-8% -$266K 0.02% 725
2024
Q3 		$3.9M Sell
62,054
-4,149
-6% -$242K 0.03% 559
2024
Q2 		$3.91M Sell
66,203
-1,889
-3% -$118K 0.03% 524
2024
Q1 		$5.43M Buy
68,092
+8,256
+14% +$631K 0.05% 367
2023
Q4 		$4.62M Sell
59,836
-14,105
-19% -$1M 0.04% 375
2023
Q3 		$5.16M Sell
73,941
-24,159
-25% -$1.71M 0.06% 317
2023
Q2 		$6.78M Sell
98,100
-16,228
-14% -$1.15M 0.08% 252
2023
Q1 		$8.41M Sell
114,328
-297,551
-72% -$25M 0.11% 203
2022
Q4 		$9.7M Buy
411,879
+14,968
+4% +$1.44M 0.26% 87
2022
Q3 		$37.9M Buy
396,911
+24,671
+7% +$2.44M 0.62% 25
2022
Q2 		$34.5M Buy
372,240
+14,831
+4% +$1.45M 0.57% 30
2022
Q1 		$36.2M Buy
357,409
+295,071
+473% +$31M 0.58% 37
2021
Q4 		$6.43M Buy
62,338
+28,145
+82% +$2.6M 0.1% 203
2021
Q3 		$2.9M Buy
34,193
+1,075
+3% +$90K 0.07% 246
2021
Q2 		$2.76M Buy
33,118
+2,132
+7% +$175K 0.07% 248
2021
Q1 		$2.33M Buy
30,986
+5,997
+24% +$437K 0.07% 254
2020
Q4 		$1.71M Sell
24,989
-29,354
-54% -$1.91M 0.06% 287
2020
Q3 		$3.17M Buy
54,343
+12,691
+30% +$790K 0.11% 188
2020
Q2 		$2.71M Buy
41,652
+3,115
+8% +$196K 0.11% 188
2020
Q1 		$2.29M Buy
38,537
+12,482
+48% +$833K 0.11% 177
2019
Q4 		$1.94M Buy
26,055
+5,370
+26% +$377K 0.08% 253
2019
Q3 		$1.32M Buy
20,685
+6,242
+43% +$370K 0.06% 292
2019
Q2 		$787K Sell
14,443
-1,118
-7% -$60.2K 0.05% 308
2019
Q1 		$839K Buy
15,561
+6,302
+68% +$389K 0.05% 299
2018
Q4 		$607 Sell
9,259
-1,466
-14% -$109K 0.04% 330
2018
Q3 		$844K Buy
10,725
+632
+6% +$45.2K 0.06% 260
2018
Q2 		$658 Buy
10,093
+701
+7% +$46.2K 0.06% 265
2018
Q1 		$573K Sell
9,392
-921
-9% -$66.1K 0.07% 251
2017
Q4 		$802K Sell
10,313
-1,503
-13% -$109K 0.11% 187
2017
Q3 		$878K Buy
11,816
+3,980
+51% +$315K 0.14% 164
2017
Q2 		$612K Buy
+7,836
New +$619K 0.11% 175
2016
Q4 		– Sell
-9,489
Closed -$844K – 263
2016
Q3 		$844K Buy
9,489
+3,431
+57% +$324K 0.27% 82
2016
Q2 		$578K Buy
+6,058
New +$604K 0.24% 82

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NewEdge Advisors's CVS Position: Q1 2026 in Review

NewEdge Advisors increased its CVS Health (CVS) stake by 22% in Q1 2026, buying an estimated $1.79M and bringing the position to 130,922 shares worth $9.4M. The position accounts for 0.03% of the portfolio, ranked #476.

NewEdge Advisors first reported a position in CVS in Q2 2016 and has held it in 38 quarters since. The position peaked at $37.9M in Q3 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • NewEdge Advisors held 130,922 shares of CVS Health worth $9.4M as of Q1 2026.
  • NewEdge Advisors bought 23,233 CVS Health shares in Q1 2026, an estimated $1.79M.
  • CVS Health made up 0.03% of NewEdge Advisors's portfolio in Q1 2026, its #476 holding.
  • NewEdge Advisors first reported a position in CVS Health in Q2 2016 and has held it in 38 quarters since.
  • NewEdge Advisors's CVS Health position peaked at $37.9M in Q3 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.